Jay Olson
Stock Analyst at Oppenheimer
(4.89)
# 262
Out of 4,639 analysts
1184
Total ratings
50.6%
Success rate
27.6%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | $23.72 | $9.35 | +153.69% | 2 | Aug 12, 2026 | |
| SGMT Sagimet Biosciences | Maintained: Buy | $33 | $9.52 | +246.64% | 8 | Aug 12, 2026 | |
| DFTX Definium Therapeutics | Maintained: Buy | $60 | $40.91 | +46.66% | 7 | Aug 7, 2026 | |
| CHRS Coherus Oncology | Maintained: Buy | $10 | $1.21 | +726.45% | 6 | Aug 6, 2026 | |
| QTTB Q32 Bio | Maintained: Buy | $40 | $15.41 | +159.57% | 10 | Aug 6, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $195 → $230 | $205.55 | +11.89% | 25 | Aug 6, 2026 | |
| BIOA BioAge Labs | Maintained: Buy | $50 | $10.67 | +368.60% | 3 | Aug 6, 2026 | |
| AMGN Amgen | Maintained: Buy | $400 → $450 | $414.30 | +8.62% | 84 | Aug 5, 2026 | |
| FTH Faeth Therapeutics | Maintained: Buy | $60 | $30.00 | +100.00% | 2 | Aug 5, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $100 | $33.80 | +195.86% | 39 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 | $161.94 | +42.03% | 90 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $107 → $120 | $121.07 | -0.88% | 84 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $275 → $300 | $203.89 | +47.14% | 99 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7658 | - | 2 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $529.65 | - | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5409 | - | 15 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $7.07 | +395.05% | 1 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $13.38 | +49.48% | 4 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.6601 | +657.46% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $4.11 | +118.98% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $750 → $650 | $370.68 | +75.35% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $13.08 | +144.65% | 1 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.77 | +464.97% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $40 | $24.69 | +62.01% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $75.50 | +85.43% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $51.33 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $92.80 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.50 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $72 | $39.52 | +82.19% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $60.57 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $7.21 | +121.91% | 4 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $36 | $4.12 | +773.79% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.80 | +525.00% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $650 | $535.27 | +21.43% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.47 | +308.16% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.58 | +171.32% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $27 | $12.02 | +124.63% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $55.42 | +62.40% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.06 | +288.35% | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $3.20 | +462.50% | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.22 | n/a | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $0.8931 | n/a | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.04 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $135.77 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $13.52 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $29.41 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $54.07 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.95 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.02 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $10 | $30.36 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.27 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.32 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $4.47 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.93 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.18 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 8 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $2.07 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $7 | $13.93 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.19 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.23 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2691 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.91 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.52 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.34 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $0.25 | $3.84 | n/a | 5 | Mar 30, 2016 |
Eupraxia Pharmaceuticals Inc.
Aug 12, 2026
Maintained: Buy
Price Target: $23.72
Current: $9.35
Upside: +153.69%
Sagimet Biosciences
Aug 12, 2026
Maintained: Buy
Price Target: $33
Current: $9.52
Upside: +246.64%
Definium Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $60
Current: $40.91
Upside: +46.66%
Coherus Oncology
Aug 6, 2026
Maintained: Buy
Price Target: $10
Current: $1.21
Upside: +726.45%
Q32 Bio
Aug 6, 2026
Maintained: Buy
Price Target: $40
Current: $15.41
Upside: +159.57%
Revolution Medicines
Aug 6, 2026
Maintained: Buy
Price Target: $195 → $230
Current: $205.55
Upside: +11.89%
BioAge Labs
Aug 6, 2026
Maintained: Buy
Price Target: $50
Current: $10.67
Upside: +368.60%
Amgen
Aug 5, 2026
Maintained: Buy
Price Target: $400 → $450
Current: $414.30
Upside: +8.62%
Faeth Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $60
Current: $30.00
Upside: +100.00%
Viking Therapeutics
Aug 3, 2026
Maintained: Buy
Price Target: $100
Current: $33.80
Upside: +195.86%
Jul 31, 2026
Maintained: Buy
Price Target: $230
Current: $161.94
Upside: +42.03%
Jul 28, 2026
Maintained: Buy
Price Target: $107 → $120
Current: $121.07
Upside: -0.88%
Jul 23, 2026
Maintained: Buy
Price Target: $275 → $300
Current: $203.89
Upside: +47.14%
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $0.7658
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $529.65
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $0.5409
Upside: -
Jul 7, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $7.07
Upside: +395.05%
Jul 7, 2026
Maintained: Buy
Price Target: $20
Current: $13.38
Upside: +49.48%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.6601
Upside: +657.46%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $4.11
Upside: +118.98%
Jun 2, 2026
Rated: Buy
Price Target: $750 → $650
Current: $370.68
Upside: +75.35%
May 28, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.08
Upside: +144.65%
May 11, 2026
Maintained: Buy
Price Target: $10
Current: $1.77
Upside: +464.97%
May 11, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $24.69
Upside: +62.01%
May 8, 2026
Maintained: Buy
Price Target: $115 → $140
Current: $75.50
Upside: +85.43%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $51.33
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $92.80
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $4.50
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: $61 → $72
Current: $39.52
Upside: +82.19%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $60.57
Upside: -
Apr 5, 2026
Rated: Buy
Price Target: $16
Current: $7.21
Upside: +121.91%
Mar 18, 2026
Maintained: Buy
Price Target: $44 → $36
Current: $4.12
Upside: +773.79%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $4.80
Upside: +525.00%
Feb 9, 2026
Maintained: Buy
Price Target: $650
Current: $535.27
Upside: +21.43%
Nov 13, 2025
Maintained: Buy
Price Target: $6
Current: $1.47
Upside: +308.16%
Nov 13, 2025
Maintained: Buy
Price Target: $7
Current: $2.58
Upside: +171.32%
Nov 7, 2025
Maintained: Buy
Price Target: $40 → $27
Current: $12.02
Upside: +124.63%
Oct 27, 2025
Maintained: Buy
Price Target: $90
Current: $55.42
Upside: +62.40%
Oct 7, 2025
Maintained: Buy
Price Target: $8
Current: $2.06
Upside: +288.35%
Oct 2, 2025
Maintained: Buy
Price Target: $18
Current: $3.20
Upside: +462.50%
Jun 16, 2025
Maintained: Hold
Price Target: n/a
Current: $9.22
Upside: n/a
Jun 16, 2025
Maintained: Buy
Price Target: $65
Current: $0.8931
Upside: n/a
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $25.04
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $135.77
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $14
Current: $13.52
Upside: n/a
Nov 8, 2024
Maintained: Hold
Price Target: $17
Current: $29.41
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $95
Current: $54.07
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.95
Upside: n/a
Nov 4, 2024
Maintained: Buy
Price Target: $9
Current: $1.02
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $9 → $10
Current: $30.36
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.27
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $13.32
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $4.47
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $9.93
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $1.18
Upside: n/a
May 8, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 22, 2019
Maintained: Buy
Price Target: $10 → $9
Current: $2.07
Upside: n/a
Aug 14, 2019
Maintained: Buy
Price Target: $15 → $7
Current: $13.93
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $1.19
Upside: n/a
Mar 24, 2019
Maintained: Buy
Price Target: n/a
Current: $1.23
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.2691
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $3.91
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $7.52
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $12.34
Upside: n/a
Mar 30, 2016
Maintained: Sell
Price Target: $2 → $0.25
Current: $3.84
Upside: n/a